Management Team

Auven Therapeutics has an experienced Management team with a strong track record in both life sciences private equity and the global drug development industries. They are supported by in-house development and IP expert teams and distinguished advisory board.

Stephen Evans-Freke
Co-Founder and Managing General Partner

Dr. Peter B. Corr
Co-Founder and Managing General Partner

Reinaldo Diaz
Managing Director, Investments & Business Development, US

Michael Forer
Managing Director, Investments & Business Development, Europe

Dr. Richard Warburg
Managing Director, Intellectual Property & Licensing

Beth Hecht
Managing Director, Chief Legal and Administrative Officer